37. 膿疱性乾癬（汎発型） Generalised pustular psoriasis Clinical trials / Disease details

臨床試験数 : 79 / 薬物数 : 57 - (DrugBank : 21) / 標的遺伝子数 : 20 - 標的パスウェイ数 : 102

7 trials found

diseases per page:

Showing 1 to 7 of 7 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03998683 (ClinicalTrials.gov)	September 3, 2019	25/6/2019	A Study of Guselkumab for the Treatment of Palmoplantar-non-Pustular Psoriasis	A Phase 3b, Multicenter, Interventional, Randomized, Placebo-controlled Study Investigating the Effi ...	Psoriasis	Drug: Guselkumab 100 mg;Drug: Placebo	Janssen-Cilag Ltd.	NULL	Completed	18 Years	N/A	All	117	Phase 3	France;Germany;Italy;Spain;United Kingdom
2	EUCTR2018-003206-58-GB (EUCTR)	29/07/2019	28/05/2019	A Clinical Study to Evaluate the Efficacy and Safety of Guselkumabfor the Treatment of Palmoplantar ...	A Phase 3b, Multicenter, Interventional, Randomized, Placebo controlled Study Investigating the Effi ...	Palmoplantar non-Pustular Psoriasis MedDRA version: 20.0;Level: PT;Classification code 10037153;Term ...	Trade Name: TREMFYA ® Product Name: Guselkumab Product Code: CNTO1959 INN or Proposed INN: GUSELKUMAB Oth ...	Janssen-Cilag International N.V.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	105	Phase 3	France;Spain;Germany;United Kingdom
3	EUCTR2018-003206-58-IT (EUCTR)	11/07/2019	15/06/2021	A Clinical Study to Evaluate the Efficacy and Safety of Guselkumabfor the Treatment of Palmoplantar ...	A Phase 3b, Multicenter, Interventional, Randomized, Placebo controlled Study Investigating the Effi ...	Palmoplantar non-Pustular Psoriasis MedDRA version: 20.0;Level: PT;Classification code 10037153;Term ...	Trade Name: TREMFYA Product Name: GUSELKUMAB Product Code: [CNTO1959] INN or Proposed INN: GUSELKUMAB Ot ...	JANSSEN CILAG INTERNATIONAL NV	NULL	Not Recruiting			Female: yes Male: yes	105	Phase 3	France;Spain;Germany;United Kingdom;Italy
4	EUCTR2018-003206-58-DE (EUCTR)	02/07/2019	25/04/2019	A Clinical Study to Evaluate the Efficacy and Safety of Guselkumabfor the Treatment of Palmoplantar ...	A Phase 3b, Multicenter, Interventional, Randomized, Placebo controlled Study Investigating the Effi ...	Palmoplantar non-Pustular Psoriasis MedDRA version: 20.0;Level: PT;Classification code 10037153;Term ...	Trade Name: TREMFYA ® Product Name: Guselkumab Product Code: CNTO1959 INN or Proposed INN: GUSELKUMAB Oth ...	Janssen-Cilag International N.V.	NULL	Not Recruiting			Female: yes Male: yes	105	Phase 3	France;Spain;Germany;Italy;United Kingdom
5	EUCTR2018-003206-58-FR (EUCTR)	29/06/2019	11/04/2019	A Clinical Study to Evaluate the Efficacy and Safety of Guselkumabfor the Treatment of Palmoplantar ...	A Phase 3b, Multicenter, Interventional, Randomized, Placebo controlled Study Investigating the Effi ...	Palmoplantar non-Pustular Psoriasis MedDRA version: 20.0;Level: PT;Classification code 10037153;Term ...	Trade Name: TREMFYA ® Product Name: Guselkumab Product Code: CNTO1959 INN or Proposed INN: GUSELKUMAB Oth ...	Janssen-Cilag International N.V.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	105	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	France;Spain;Germany;United Kingdom
6	EUCTR2018-003206-58-ES (EUCTR)	20/06/2019	08/05/2019	A Clinical Study to Evaluate the Efficacy and Safety of Guselkumabfor the Treatment of Palmoplantar ...	A Phase 3b, Multicenter, Interventional, Randomized, Placebo controlled Study Investigating the Effi ...	Palmoplantar non-Pustular Psoriasis MedDRA version: 20.0;Level: PT;Classification code 10037153;Term ...	Trade Name: TREMFYA ® Product Name: Guselkumab Product Code: CNTO1959 INN or Proposed INN: GUSELKUMAB Oth ...	Janssen-Cilag International N.V.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	105	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	France;Spain;Germany;United Kingdom
7	NCT02343744 (ClinicalTrials.gov)	January 19, 2015	16/1/2015	An Efficacy and Safety Study of CNTO1959 (Guselkumab) in the Treatment of Participants With Generali ...	A Phase 3, Multicenter, Open-Label Study Evaluating the Efficacy and Safety of CNTO1959 (Guselkumab) ...	Pustular Psoriasis	Drug: Guselkumab	Janssen Pharmaceutical K.K.	NULL	Completed	20 Years	N/A	All	21	Phase 3	Japan

First Previous1Next Last